Assertio Holdings Inc banner
A

Assertio Holdings Inc
NASDAQ:ASRT

Watchlist Manager
Assertio Holdings Inc
NASDAQ:ASRT
Watchlist
Price: 11.87 USD -1.66% Market Closed
Market Cap: $76.2m

Assertio Holdings Inc
Other Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Assertio Holdings Inc
Other Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Items CAGR 3Y CAGR 5Y CAGR 10Y
A
Assertio Holdings Inc
NASDAQ:ASRT
Other Items
-$12.7m
CAGR 3-Years
29%
CAGR 5-Years
N/A
CAGR 10-Years
36%
Johnson & Johnson
NYSE:JNJ
Other Items
-$18.8B
CAGR 3-Years
-31%
CAGR 5-Years
-1%
CAGR 10-Years
-16%
Bristol-Myers Squibb Co
NYSE:BMY
Other Items
-$2.8B
CAGR 3-Years
N/A
CAGR 5-Years
23%
CAGR 10-Years
-14%
Pfizer Inc
NYSE:PFE
Other Items
$1.3B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Other Items
-$9.6B
CAGR 3-Years
-156%
CAGR 5-Years
-14%
CAGR 10-Years
-11%
Eli Lilly and Co
NYSE:LLY
Other Items
-$123m
CAGR 3-Years
46%
CAGR 5-Years
12%
CAGR 10-Years
N/A
No Stocks Found

Assertio Holdings Inc
Glance View

Assertio Holdings, Inc. engages in the provision of commercial pharmaceutical products. The company is headquartered in Lake Forest, Illinois and currently employs 19 full-time employees. The firm's primary marketed products are INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, INDOCIN (indomethacin) Oral Suspension, CAMBIA (diclofenac potassium for oral solution), Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray and Zipsor (diclofenac potassium) Liquid filled capsules. The firm has other commercially available products, which include OXAYDO (oxycodone HCI, USP) tablets for oral use only. Assertio and Zyla are the registered trademarks of the Company. INDOCIN products are used for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease, moderate to severe ankylosing spondylitis, moderate to severe osteoarthritis, acute painful shoulder (bursitis and/or tendinitis) and acute gouty arthritis.

ASRT Intrinsic Value
27.33 USD
Undervaluation 57%
Intrinsic Value
Price
A

See Also

What is Assertio Holdings Inc's Other Items?
Other Items
-12.7m USD

Based on the financial report for Sep 30, 2025, Assertio Holdings Inc's Other Items amounts to -12.7m USD.

What is Assertio Holdings Inc's Other Items growth rate?
Other Items CAGR 10Y
36%

Over the last year, the Other Items growth was 75%. The average annual Other Items growth rates for Assertio Holdings Inc have been 29% over the past three years , and 36% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett